journal article·2020-12

Synthesis and photodynamic properties of pyrazole-indole hybrids in the human skin melanoma cell line G361

Gabrielė Varvuolytė, Lukáš Malina, Aurimas Bieliauskas, Barbora Hošíková, Helena Simerská, Hana Kolářová, Neringa Kleizienė, Vladimír Kryštof, Algirdas Šačkus, Asta Žukauskaitė

Dyes and Pigments· Volume 183
Publisher page

Abstract

Abstract Three conjugated pyrazole-indole hybrids, 5, 7 and 10, were synthesized from easily accessible 3-(hexyloxy)-1-phenyl-1H-pyrazole-4-carbaldehyde 1 and 5-iodo-3,3-dimethyl-2-phenyl-3H-indole 4 employing olefination reactions (Wittig, Ramirez), Vilsmeier-Haack formylation and palladium-catalysed cross coupling reactions (ligand-free Heck, Sonogashira). The compounds displayed no cytotoxicity in the melanoma cell line G361 unless irradiated with visible blue light (414 nm), and the potency of the compounds increased with light intensity. Lead compound 7 displayed EC50 values of 3.08, 0.26 and 0.05 μM in cells irradiated with 1, 10 and 50 J/cm2, respectively. The following experiments revealed increased levels of reactive oxygen species in treated cells and a decrease in JC-1 polymer aggregation within the mitochondria, suggesting mitochondrial membrane depolarization. In addition, extensive DNA fragmentation was detected using the comet assay and by detection of phosphorylated histone H2A.X, the level of which increased with both increased compound concentration and irradiation energy. In control experiments, cells kept either in the dark or without compound 7 did not show any DNA damage. Overall, the results demonstrated that fluorescent pyrazole-indole hybrids may serve as an interesting source of photosensitizing compounds with anticancer activity.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics · Porphyrin and Phthalocyanine Chemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (73)

Show source-provided references
1. Photodynamic therapy: a hot topic in dermato-oncology (Review)
2. Photodynamic therapy for human malignancies with superficial and interstitial illumination10.1533/9780857097545.4.760 ↗
3. Photodynamic therapy (PDT) for lung cancers10.1016/S1556-0864(15)31616-6 ↗
4. Photodynamic therapy treatment of early oral and laryngeal cancers10.1111/j.1751-1097.2007.00153.x ↗
5. Curcumin-mediated Photodynamic Therapy for the treatment of oral infections—a review10.1016/j.pdpdt.2018.01.016 ↗
6. Photodynamic therapy (PDT) of cancer: from local to systemic treatment10.1039/c5pp00132c ↗
7. Oncologic photodynamic therapy photosensitizers: a clinical review10.1016/j.pdpdt.2010.02.001 ↗
8. Photodynamic therapy in cancer treatment - an update review10.20517/2394-4722.2018.83 ↗
9. Clinical development of photodynamic agents and therapeutic applications10.1186/s40824-018-0140-z ↗
10. Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents10.1016/j.ejmech.2017.08.070 ↗
11. An updated overview on the development of new photosensitizers for anticancer photodynamic therapy10.1016/j.apsb.2017.09.003 ↗
12. BODIPY dyes in photodynamic therapy10.1039/C2CS35216H ↗
13. Trifluoromethyl boron dipyrromethene derivatives as potential photosensitizers for photodynamic therapy10.3390/molecules23020458 ↗
14. Boron dipyrromethene (BODIPY)-based photosensitizers for photodynamic therapy10.1039/c2ra21404k ↗
15. Halogenated aza-BODIPY for imaging-guided synergistic photodynamic and photothermal tumor therapy10.1002/adhm.201800606 ↗
16. Tuning photosensitized singlet oxygen generation efficiency of novel aza-BODIPY dyes10.1021/ol102562k ↗
17. Synthesis, photophysical properties and applications of NIR absorbing unsymmetrical squaraines: a review10.1016/j.dyepig.2019.107645 ↗
18. Photodynamic activity of anthraquinones isolated from Heterophyllaea pustulata Hook f. (Rubiaceae) on MCF-7c3 breast cancer cells10.1016/j.phymed.2011.05.008 ↗
19. An efficient rose bengal based nanoplatform for photodynamic therapy10.1002/chem.201404296 ↗
20. Optimized heptamethine cyanines for photodynamic therapy10.1021/acsabm.8b00414 ↗
21. Iodinated cyanine dyes: a new class of sensitisers for use in NIR activated photodynamic therapy (PDT)10.1039/C6CC09624G ↗
22. Enhanced photodynamic cancer treatment by mitochondria-targeting and brominated near-infrared fluorophores10.1002/advs.201700481 ↗
23. Interactions of merocyanine 540 with human brain tumor cells10.1016/0887-8994(92)90031-S ↗
24. Near-infrared photothermal/photodynamic therapy with indocyanine green induces apoptosis of hepatocellular carcinoma cells through oxidative stress10.1038/s41598-017-14401-0 ↗
25. Comparative effects of photodynamic therapy mediated by curcumin on standard and clinical isolate of Streptococcus mutans10.5005/jp-journals-10024-1626 ↗
26. Photodynamic potentialities of some phenothiazine derivatives10.1007/BF02027852 ↗
27. Efficient radical‐enhanced intersystem crossing in an NDI‐TEMPO dyad: photophysics, electron spin polarization, and application in photodynamic therapy10.1002/chem.201804212 ↗
28. A near-infrared heptamethine aminocyanine dye with a long-lived excited triplet state for photodynamic therapy10.1039/C8CC04582H ↗
29. Fluorescence lifetime properties of near-infrared cyanine dyes in relation to their structures10.1016/j.jphotochem.2008.09.008 ↗
30. BODIPY photosensitizers based on PET and heavy atom effect: a comparative study on the efficient formation of excited triplet state and singlet oxygen in BODIPY dimers and monomers10.1016/j.jphotochem.2017.07.019 ↗
31. Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug10.1016/j.pdpdt.2018.12.005 ↗
32. Squaraines bearing halogenated moieties as anticancer photosensitizers: synthesis, characterization and biological evaluation10.1016/j.ejmech.2016.02.035 ↗
33. Cosmetic dyes as potential photosensitizers of singlet oxygen generation10.1016/j.dyepig.2020.108248 ↗
34. New photosensitizers for photodynamic therapy10.1042/BJ20150942 ↗
35. A review of progress in clinical photodynamic therapy10.1177/153303460500400308 ↗
36. Dye sensitizers for photodynamic therapy10.3390/ma6030817 ↗
37. Fluorescence sensing based on phenylenediacetonitrile doped into polymer host10.1016/j.jlumin.2015.10.040 ↗
38. Morphology and emission tuning in fluorescent nanoparticles based on phenylenediacetonitrile10.1021/jp507707f ↗
39. Multifunctional polyconjugated molecules with carbazolyl and pyrazolyl moieties for optoelectronic applications10.1016/j.synthmet.2009.11.038 ↗
40. Synthesis of pyrazolo[4′,3′:3,4]pyrido[1,2-a]benzimidazoles and related new ring systems by tandem cyclisation of vic-alkynylpyrazole-4-carbaldehydes with (het)aryl-1,2-diamines and investigation of their optical properties10.1016/j.tet.2015.03.092 ↗
41. Microwave-assisted synthesis of new fluorescent indoline-based building blocks by ligand free Suzuki-Miyaura cross-coupling reaction in aqueous media10.1016/j.tet.2016.04.010 ↗
42. Improving the photochromic properties of indolo[2,1-b][1,3]benzoxazines with phenylic substituents10.1016/j.jphotochem.2013.12.022 ↗
43. Synthesis of new fluorescent building blocks via the microwave-assisted annulation reaction of 1,1,2-trimethyl-1H-benzo[e]indole with acrylic acid and its derivatives10.1016/j.tet.2014.01.070 ↗
44. Facile synthesis of spiro[benzo[e]indole-2,2′-piperidine] derivatives and their transformation to novel fluorescent scaffolds10.1016/j.tet.2012.08.073 ↗
45. Fast and stable light-driven molecular switch based on a 5a,13-methanoindolo[2,1-b][1,3]benzoxazepine ring system10.1016/j.dyepig.2014.09.006 ↗
46. A new synthesis of 1,1-dibromoölefins via phosphine-dibromomethylenes. The reaction of triphenylphosphine with carbon tetrabromide10.1021/ja00868a057 ↗
47. Cs2CO3-mediated synthesis of terminal alkynes from 1,1-dibromo-1-alkenes10.1016/j.tetlet.2010.12.071 ↗
48. A tailored spirooxazine dimer as a photoswitchable binding tool10.1039/b909496b ↗
49. Synthesis and anti-mitotic activity of 2,4- or 2,6-disubstituted- and 2,4,6-trisubstituted-2H-pyrazolo[4,3-c]pyridines10.1016/j.ejmech.2018.03.037 ↗
50. Ring-closing metathesis as a key step to construct 2,6-dihydropyrano[2,3-c]pyrazole ring system10.24820/ark.5550190.p010.407 ↗
51. Synthesis of electroactive hydrazones derived from 3-(10-alkyl-10H-phenothiazin-3-yl)-2-propenals and their corresponding 3,3′-bispropenals10.1016/j.tet.2012.03.010 ↗
52. CSEARCH: a computer program for identification of organic compounds and fully automated assignment of carbon-13 nuclear magnetic resonance spectra
53. Braun · 1998
54. Heteronuclear two-bond Correlation: suppressing heteronuclear three-bond or higher NMR correlations while enhancing two-bond correlations even for vanishing 2JCH10.1021/ja050878w ↗
55. Using LR-HSQMBC to observe long-range 1H–15N correlations10.1016/j.tetlet.2014.04.060 ↗
56. LR-HSQMBC: a sensitive NMR technique to probe very long-range heteronuclear coupling pathways10.1021/jo500333u ↗
57. NMR structure elucidation of small organic molecules and natural products: choosing ADEQUATE vs HMBC10.1021/np500445s ↗
58. The therapeutic voyage of pyrazole and its analogs: a review10.1016/j.ejmech.2016.04.077 ↗
59. Review: biologically active pyrazole derivatives10.1039/C6NJ03181A ↗
60. Recent development in indole derivatives as anticancer agents for breast cancer10.2174/1871520619666190312125602 ↗
61. Indole: a privileged scaffold for the design of anti-cancer agents10.1016/j.ejmech.2019.111691 ↗
62. Nanoparticles to mediate X-ray-induced photodynamic therapy and Cherenkov radiation photodynamic therapy10.1002/wnan.1541 ↗
63. Photodynamic therapy – mechanisms, photosensitizers and combinations10.1016/j.biopha.2018.07.049 ↗
64. C-MYC and C-FOS expression changes and cellular aspects of the photodynamic reaction with photosensitizers TMPyP and ClAlPcS210.1016/j.jphotobiol.2014.12.003 ↗
65. Size-selected graphene oxide loaded with photosensitizer (TMPyP) for targeting photodynamic therapy in vitro10.3390/pr8020251 ↗
66. A review of nanoparticle photosensitizer drug delivery uptake systems for photodynamic treatment of lung cancer10.1016/j.pdpdt.2018.03.006 ↗
67. Molecular effectors of multiple cell death pathways initiated by photodynamic therapy10.1016/j.bbcan.2007.07.001 ↗
68. Comparison of cellular death pathways after mTHPC-mediated photodynamic therapy (PDT) in five human cancer cell lines10.3390/cancers11050702 ↗
69. Transition metal complexes and photodynamic therapy from a tumor-centered approach: challenges, opportunities, and highlights from the development of TLD143310.1021/acs.chemrev.8b00211 ↗
70. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light10.1067/mjd.2001.114288 ↗
71. Blue light versus red light for photodynamic therapy of basal cell carcinoma in patients with Gorlin syndrome: a bilaterally controlled comparison study10.1016/j.pdpdt.2018.02.009 ↗
72. Bichromophoric photochromes based on the opening and closing of a single oxazine ring10.1021/jo7017119 ↗
73. Bajgar · 2015